NO972278L - Fluorerte vitamin D3-analoger - Google Patents

Fluorerte vitamin D3-analoger

Info

Publication number
NO972278L
NO972278L NO972278A NO972278A NO972278L NO 972278 L NO972278 L NO 972278L NO 972278 A NO972278 A NO 972278A NO 972278 A NO972278 A NO 972278A NO 972278 L NO972278 L NO 972278L
Authority
NO
Norway
Prior art keywords
double bond
hydrogen
bond
alkyl
independently
Prior art date
Application number
NO972278A
Other languages
English (en)
Other versions
NO972278D0 (no
Inventor
Percy Sarwood Manchand
Jr John Joseph Nestor
Milan Radoje Uskokovic
Brian Henry Vickery
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO972278D0 publication Critical patent/NO972278D0/no
Publication of NO972278L publication Critical patent/NO972278L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Nye fluorerte vitamin D3-analoger med formel %6 24k2>R3, l\ OH hvor: X er (H,H) eller =CH2; Ri og Rj er, uavhengig av hverandre, hydrogen, (Ci-C4)-alkyl eller fluor- alkyl, eller R^ og R2 sammen med C-20 danner (Cj-Cg)- cykloalkyl eller cyklofluoralkyl, eller R^ og R2 sammen danner =CH2; R3 og R4 er, uavhengig av hver- andre, (C]^-C4)-alkyl eller fluoralkyl, eller R3 og R4 saiTimen med C-25 danner (C3-C9)-cykloalkyl eller cyklofluoralkyl; A er en enkeltbinding eller en dobbeltbinding; og B er en dobbeltbinding eller en trippelbinding; unntatt: (i) når X er =CH2, R3 og R4 begge er CF3, A er en dobbeltbinding og en av R^^ og Rj er hydrogen, da kan den andre av R^ og Rj ikke være CH3; (ii) når X er =CH2, R3 og R4 begge er (C^- Cj)-alkyl, A er en dobbeltbinding og Rj er hydrogen, da kan R^ ikke være CH3; (iii) når X er =CH2, R3 og R4 begge er (CiL-C4)-alkyl, A er en dobbeltbinding og R^ er hydrogen, da kan R2 ikke være CH3; (iv) når X er =CH2, en av R3 og R4 er CF3, A er en dobbelt- binding. Ri er CH3 og Rj er hydrogen, da kan den andre av R3 og R4 ikke være CH3; og (v) når X er (H,H), R3 og R4 begge er CF3, A er en dobbeltbinding, B er en trippelbinding og Rj er hydrogen, da kan R^ ikke være CH3; og forbindelsene i formel I ovenfor hvor: X er (H,H) eller =CH2; R-^ og R2 er, uavhengig av hverandre, hydrogen, (Ci-C4)-alkyl eller fluor- alkyl, eller R^ og Rj sammen med C-20 danner (C3-Cg)- cykloalkyl eller cyklofluoralkyl, eller R^ og Rj sammen c-:inner =CH2; R3 og R^ er, uavhengig av hver- andre, ( 2^^-04)-alkyl eller fluoralkyl, eller R3 og R4 sammen med C-25 danner (C3-C9)-cykloalkyl eller cyklofluoralkyl; A er en enkeltbinding eller en dobb'?ltbinding; og B er en dobbeltbinding eller en trippelbinding; unntatt hvor R3 og R4 begge er CF3 og A er en dobbeltbinding og B er en trippelbinding og R2 er hydrogen, da kan R^ ikke være CH3, er nyttige ved behandling av osteoporose.
NO972278A 1996-05-23 1997-05-20 Fluorerte vitamin D3-analoger NO972278L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1821996P 1996-05-23 1996-05-23
US3990197P 1997-03-19 1997-03-19

Publications (2)

Publication Number Publication Date
NO972278D0 NO972278D0 (no) 1997-05-20
NO972278L true NO972278L (no) 1997-11-24

Family

ID=26690870

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972278A NO972278L (no) 1996-05-23 1997-05-20 Fluorerte vitamin D3-analoger

Country Status (26)

Country Link
EP (1) EP0808832B1 (no)
JP (1) JP2859248B2 (no)
KR (1) KR100253961B1 (no)
CN (1) CN100402497C (no)
AR (1) AR007776A1 (no)
AT (1) ATE238278T1 (no)
AU (1) AU733970B2 (no)
BR (1) BR9703385A (no)
CA (1) CA2205315C (no)
CO (1) CO4940503A1 (no)
CZ (1) CZ157797A3 (no)
DE (1) DE69721123T2 (no)
DK (1) DK0808832T3 (no)
ES (1) ES2195049T3 (no)
HR (1) HRP970272A2 (no)
HU (1) HUP9700928A3 (no)
IL (1) IL120844A0 (no)
MA (1) MA24250A1 (no)
NO (1) NO972278L (no)
NZ (1) NZ314840A (no)
PE (1) PE66798A1 (no)
PL (1) PL320130A1 (no)
PT (1) PT808832E (no)
SG (1) SG70010A1 (no)
TR (1) TR199700416A2 (no)
YU (1) YU20097A (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
DE19935771A1 (de) 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
WO2002013832A1 (fr) * 2000-08-17 2002-02-21 Chugai Seiyaku Kabushiki Kaisha Agent therapeutique destine au traitement de l'osteoporose
MXPA04002640A (es) * 2001-09-21 2004-06-07 Hoffmann La Roche Esteres de analogos de 3-desoxi-vitamina d3.
AU2004203436A1 (en) 2003-09-24 2005-04-14 Bioxell Spa Compound and use in treatment
CN101106985A (zh) * 2004-09-24 2008-01-16 拜奥艾克塞尔股份公司 20-环烷基,26,27-烷基/卤代烷基维生素d3化合物及其使用方法
EP1879596A4 (en) * 2005-03-23 2009-01-21 Bioxell Spa 20 ALKYL, GEMINI VITAMIN D3 COMPOUNDS AND METHOD OF USE THEREOF
ES2541719T3 (es) * 2010-10-25 2015-07-24 Teijin Pharma Limited Derivado de 23-ino-vitamina D3

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4141746A1 (de) * 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate
DE4220757A1 (de) * 1992-06-24 1994-01-05 Schering Ag Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
WO1997016193A1 (en) * 1995-10-27 1997-05-09 F. Hoffmann-La Roche Ag Pharmaceutical composition for treating osteoporosis

Also Published As

Publication number Publication date
KR970074764A (ko) 1997-12-10
PE66798A1 (es) 1998-10-22
NO972278D0 (no) 1997-05-20
KR100253961B1 (ko) 2000-04-15
IL120844A0 (en) 1997-09-30
DK0808832T3 (da) 2003-08-11
DE69721123D1 (de) 2003-05-28
PL320130A1 (en) 1997-11-24
JP2859248B2 (ja) 1999-02-17
CA2205315C (en) 2006-10-24
TR199700416A2 (xx) 1997-12-21
CN100402497C (zh) 2008-07-16
MX9703775A (es) 1998-06-30
ATE238278T1 (de) 2003-05-15
CN1172801A (zh) 1998-02-11
AR007776A1 (es) 1999-11-24
HU9700928D0 (en) 1997-07-28
JPH1045714A (ja) 1998-02-17
CO4940503A1 (es) 2000-07-24
YU20097A (sh) 1999-09-27
CZ157797A3 (en) 1997-12-17
DE69721123T2 (de) 2004-01-08
EP0808832B1 (en) 2003-04-23
SG70010A1 (en) 2000-01-25
BR9703385A (pt) 1998-09-15
AU733970B2 (en) 2001-05-31
HUP9700928A3 (en) 1999-07-28
NZ314840A (en) 1998-11-25
EP0808832A2 (en) 1997-11-26
ES2195049T3 (es) 2003-12-01
HUP9700928A2 (hu) 1998-01-28
CA2205315A1 (en) 1997-11-23
PT808832E (pt) 2003-07-31
MA24250A1 (fr) 1998-04-01
EP0808832A3 (en) 1999-02-03
HRP970272A2 (en) 1998-04-30
AU2357697A (en) 1997-11-27

Similar Documents

Publication Publication Date Title
ZA842185B (en) New n-aryl-n'-cycloalkylalkanoyl-piperazine and process for the production thereof
MY132867A (en) Acid-stable borates for photopolymerization
ATE133661T1 (de) Fluorierte kohlenwasserstoffderivate, ihre verwendung in kosmetischen zusammensetzungen, verfahren zu ihrer herstellung und sie enthaltende kosmetische zusammensetzungen
MY113419A (en) Mixtures of mono-and bis-resorclnyl-2-nydroxyphenyltriazine uv absorbers and their use as stabilizers for organic materials
NO972278L (no) Fluorerte vitamin D3-analoger
ID18576A (id) Senyawa antara untuk membuat turunan-turunan steroid yang digunakan dalam pengobatan hipertropi prostatik dan pembuatannya
YU47298B (sh) Derivati 16-dehidro-vitamina d3
ES8303395A1 (es) "procedimiento de preparar compuestos benzoxepinicos y analogos".
GB2283016A (en) Scavenging of hydrogen sulphide
IL83141A (en) Solutions of oxazophosphorins having improved stability and their preparation
AU1706495A (en) Stabilizer mixture made up of chromane derivatives, organic phosphites or phosphonites and amines
GB1477293A (en) Tetralone and indanone derivatives and process for their preparations
AU6559994A (en) Stable moulding or spinning compound containing cellulose
EA199800468A1 (ru) 25-гидрокси-16-ен-26,27-бисгомохолекальциферолы
JPS5735506A (en) Bleaching cosmetic
NO940113L (no) Syntese av 2-fenyl-substituerte 1,3-propandioler
FI832007L (fi) En ny mikroorganismstam chromobacterium violaceum, medelst denna stam framstaellda farmaceutiskt aktiva foereningar, ett foerfarande foer framstaellning av foereningarna och anvaendning av dessa foereningar som laekemedel
AU683148B2 (en) Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases
HU9502179D0 (en) Piperazine derivatives for producing alkyl-trazodon derivatives and process for producing them
ES2150564T3 (es) Proceso para la preparacion de derivados de 5,6-dihidroxi-2-amino-1,2,3,4-tetrahidronaftaleno.
FI925618A0 (fi) Etanoladdukter av 6-sulfonylsubstituerade 3-hydroxikromaner och deras anvaendning som inhalationsmedel vid sjukdomar
JPS5716852A (en) Nitrile derivative, its preparation, and fibrosis suppressing agent containing the same
AU3093689A (en) Adhesive
SU1837613A1 (ru) Гидрофобизатор для обработки бетона
US4268669A (en) 9-Deoxy-9-methylene-5,6-didehydro-PGF1 amides